球蟲藥市場：按類型、動物類型分類 - 全球預測 2024-2030

預計2023年球蟲藥市場規模為16.2億美元，預計2024年將達17.6億美元，2030年將達30.4億美元，複合年成長率為9.39%。

全球球蟲藥市場

FPNV定位矩陣

FPNV定位矩陣對於評估球蟲藥市場至關重要。我們檢視與業務策略和產品滿意度相關的關鍵指標，以對供應商進行全面評估。這種深入的分析使用戶能夠根據自己的要求做出明智的決策。根據評估，供應商被分為四個成功程度不同的像限：前沿（F）、探路者（P）、利基（N）和重要（V）。

市場佔有率分析

市場佔有率分析是一種綜合工具，可以球蟲藥市場供應商的現狀進行深入而詳細的研究。全面比較和分析供應商在整體收益、基本客群和其他關鍵指標方面的貢獻，以便更好地了解公司的績效及其在爭奪市場佔有率時面臨的挑戰。此外，該分析還提供了對該行業競爭特徵的寶貴見解，包括在研究基準年觀察到的累積、分散主導地位和合併特徵等因素。這種詳細程度的提高使供應商能夠做出更明智的決策並制定有效的策略，從而在市場上獲得競爭優勢。

該報告對以下幾個方面提供了寶貴的見解：

1-市場滲透率：提供有關主要企業所服務的市場的全面資訊。

2-市場開拓：我們深入研究利潤豐厚的新興市場，並分析它們在成熟細分市場中的滲透率。

3- 市場多元化：提供有關新產品發布、開拓地區、最新發展和投資的詳細資訊。

4-競爭力評估與資訊：對主要企業的市場佔有率、策略、產品、認證、監管狀況、專利狀況、製造能力等進行全面評估。

5- 產品開發與創新：提供對未來技術、研發活動和突破性產品開發的見解。

本報告解決了以下關鍵問題：

1-球蟲藥市場的市場規模與預測是多少？

2-球蟲藥市場預測期間需要考慮投資的產品、細分市場、應用和領域有哪些？

3-球蟲藥市場的技術趨勢和法律規範是什麼？

4-球蟲藥市場主要供應商的市場佔有率是多少？

5-進入球蟲藥市場的合適型態和策略性手段是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

• 市場動態
  • 促進因素
    • 牲畜球蟲病率上升
    • 畜牧業實踐持續改善
    • 增加政府投資改善動物福利
  • 抑制因素
    • 政府球蟲藥物的嚴格規定
  • 機會
    • 先進球蟲藥物的開發
    • 介紹製造商預防球蟲的努力
  • 任務
    • 替代藥物和治療方法的可用性
• 市場區隔分析
• 市場趨勢分析
• 高通膨的累積效應
• 波特五力分析
• 價值鍊和關鍵路徑分析
• 法律規範

第6章球蟲藥市場：依類型

• 抗生素球蟲藥
• 化學衍生物球蟲藥
• 離子載體球蟲劑

第7章球蟲藥市場：依動物類型

• 水產養殖
• 家畜
• 家禽

第8章 北美、南美球蟲藥市場

• 阿根廷
• 巴西
• 加拿大
• 墨西哥
• 美國

第9章亞太球蟲藥市場

• 澳洲
• 中國
• 印度
• 印尼
• 日本
• 馬來西亞
• 菲律賓
• 新加坡
• 韓國
• 台灣
• 泰國
• 越南

第10章 歐洲、中東和非洲抗球蟲藥市場

• 丹麥
• 埃及
• 芬蘭
• 法國
• 德國
• 以色列
• 義大利
• 荷蘭
• 奈及利亞
• 挪威
• 波蘭
• 卡達
• 俄羅斯
• 沙烏地阿拉伯
• 南非
• 西班牙
• 瑞典
• 瑞士
• 土耳其
• 阿拉伯聯合大公國
• 英國

第11章競爭形勢

• FPNV定位矩陣
• 市場佔有率分析：主要企業
• 主要企業競爭情境分析

第12章競爭產品組合

• 主要公司簡介
  • Bioproperties Pty Ltd.
  • Boehringer Ingelheim International GmbH
  • Ceva Sante Animale
  • Cronus Pharma
  • Elanco Animal Health Inc.
  • Fengchen Group Co., Ltd.
  • Hipra Laboratories, SA
  • Huvepharma EOOD
  • Impextraco NV
  • Intas Pharmaceuticals Ltd.
  • Jurox Pty Limited
  • Kaken Pharmaceutical Co. Ltd.
  • Kemin Industries Inc.
  • Merck & Co., Inc.
  • Novartis AG
  • Phibro Animal Health Corporation
  • Qilu Animal Health Products Co., Ltd.
  • Salius Pharma Pvt. Ltd.
  • TOKU-E
  • VH Group
  • Virbac Group
  • VIVAN Life Sciences Pvt. Limited
  • Zoetis Inc.
• 主要產品系列

第13章附錄

• 討論指南
• 關於許可證和定價

[185 Pages Report] The Anticoccidial Drugs Market size was estimated at USD 1.62 billion in 2023 and expected to reach USD 1.76 billion in 2024, at a CAGR 9.39% to reach USD 3.04 billion by 2030.

Global Anticoccidial Drugs Market

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Anticoccidial Drugs Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Anticoccidial Drugs Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Anticoccidial Drugs Market, highlighting leading vendors and their innovative profiles. These include Bioproperties Pty Ltd., Boehringer Ingelheim International GmbH, Ceva Sante Animale, Cronus Pharma, Elanco Animal Health Inc., Fengchen Group Co., Ltd., Hipra Laboratories, S.A., Huvepharma EOOD, Impextraco NV, Intas Pharmaceuticals Ltd., Jurox Pty Limited, Kaken Pharmaceutical Co. Ltd., Kemin Industries Inc., Merck & Co., Inc., Novartis AG, Phibro Animal Health Corporation, Qilu Animal Health Products Co., Ltd., Salius Pharma Pvt. Ltd., TOKU-E, VH Group, Virbac Group, VIVAN Life Sciences Pvt. Limited, and Zoetis Inc..

Market Segmentation & Coverage

This research report categorizes the Anticoccidial Drugs Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Type
  • Antibiotic Anticoccidials
  • Chemical Derivative Anticoccidials
  • Ionophore Anticoccidials
• Animal Type
  • Aquaculture
  • Livestock
  • Poultry
• Region
  • Americas
    • Argentina
    • Brazil
    • Canada
    • Mexico
    • United States
      • California
      • Florida
      • Illinois
      • New York
      • Ohio
      • Pennsylvania
      • Texas
  • Asia-Pacific
    • Australia
    • China
    • India
    • Indonesia
    • Japan
    • Malaysia
    • Philippines
    • Singapore
    • South Korea
    • Taiwan
    • Thailand
    • Vietnam
  • Europe, Middle East & Africa
    • Denmark
    • Egypt
    • Finland
    • France
    • Germany
    • Israel
    • Italy
    • Netherlands
    • Nigeria
    • Norway
    • Poland
    • Qatar
    • Russia
    • Saudi Arabia
    • South Africa
    • Spain
    • Sweden
    • Switzerland
    • Turkey
    • United Arab Emirates
    • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Anticoccidial Drugs Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Anticoccidial Drugs Market?

3. What are the technology trends and regulatory frameworks in the Anticoccidial Drugs Market?

4. What is the market share of the leading vendors in the Anticoccidial Drugs Market?

5. Which modes and strategic moves are suitable for entering the Anticoccidial Drugs Market?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Limitations
• 1.7. Assumptions
• 1.8. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

• 4.1. Introduction
• 4.2. Anticoccidial Drugs Market, by Region

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Rising prevalence of coccidiosis in livestock
    • 5.1.1.2. Growing improvements in animal husbandry practices
    • 5.1.1.3. Increasing government investments in improving animal welfare
  • 5.1.2. Restraints
    • 5.1.2.1. Stringent government regulations for anticoccidial drugs
  • 5.1.3. Opportunities
    • 5.1.3.1. Development of advanced anticoccidial drugs
    • 5.1.3.2. Introduction of coccidiosis management initiatives by manufacturers
  • 5.1.4. Challenges
    • 5.1.4.1. Availability of alternative medicines and treatments
• 5.2. Market Segmentation Analysis
• 5.3. Market Trend Analysis
• 5.4. Cumulative Impact of High Inflation
• 5.5. Porter's Five Forces Analysis
  • 5.5.1. Threat of New Entrants
  • 5.5.2. Threat of Substitutes
  • 5.5.3. Bargaining Power of Customers
  • 5.5.4. Bargaining Power of Suppliers
  • 5.5.5. Industry Rivalry
• 5.6. Value Chain & Critical Path Analysis
• 5.7. Regulatory Framework

6. Anticoccidial Drugs Market, by Type

• 6.1. Introduction
• 6.2. Antibiotic Anticoccidials
• 6.3. Chemical Derivative Anticoccidials
• 6.4. Ionophore Anticoccidials

7. Anticoccidial Drugs Market, by Animal Type

• 7.1. Introduction
• 7.2. Aquaculture
• 7.3. Livestock
• 7.4. Poultry

8. Americas Anticoccidial Drugs Market

• 8.1. Introduction
• 8.2. Argentina
• 8.3. Brazil
• 8.4. Canada
• 8.5. Mexico
• 8.6. United States

9. Asia-Pacific Anticoccidial Drugs Market

• 9.1. Introduction
• 9.2. Australia
• 9.3. China
• 9.4. India
• 9.5. Indonesia
• 9.6. Japan
• 9.7. Malaysia
• 9.8. Philippines
• 9.9. Singapore
• 9.10. South Korea
• 9.11. Taiwan
• 9.12. Thailand
• 9.13. Vietnam

10. Europe, Middle East & Africa Anticoccidial Drugs Market

• 10.1. Introduction
• 10.2. Denmark
• 10.3. Egypt
• 10.4. Finland
• 10.5. France
• 10.6. Germany
• 10.7. Israel
• 10.8. Italy
• 10.9. Netherlands
• 10.10. Nigeria
• 10.11. Norway
• 10.12. Poland
• 10.13. Qatar
• 10.14. Russia
• 10.15. Saudi Arabia
• 10.16. South Africa
• 10.17. Spain
• 10.18. Sweden
• 10.19. Switzerland
• 10.20. Turkey
• 10.21. United Arab Emirates
• 10.22. United Kingdom

11. Competitive Landscape

• 11.1. FPNV Positioning Matrix
• 11.2. Market Share Analysis, By Key Player
• 11.3. Competitive Scenario Analysis, By Key Player

12. Competitive Portfolio

• 12.1. Key Company Profiles
  • 12.1.1. Bioproperties Pty Ltd.
  • 12.1.2. Boehringer Ingelheim International GmbH
  • 12.1.3. Ceva Sante Animale
  • 12.1.4. Cronus Pharma
  • 12.1.5. Elanco Animal Health Inc.
  • 12.1.6. Fengchen Group Co., Ltd.
  • 12.1.7. Hipra Laboratories, S.A.
  • 12.1.8. Huvepharma EOOD
  • 12.1.9. Impextraco NV
  • 12.1.10. Intas Pharmaceuticals Ltd.
  • 12.1.11. Jurox Pty Limited
  • 12.1.12. Kaken Pharmaceutical Co. Ltd.
  • 12.1.13. Kemin Industries Inc.
  • 12.1.14. Merck & Co., Inc.
  • 12.1.15. Novartis AG
  • 12.1.16. Phibro Animal Health Corporation
  • 12.1.17. Qilu Animal Health Products Co., Ltd.
  • 12.1.18. Salius Pharma Pvt. Ltd.
  • 12.1.19. TOKU-E
  • 12.1.20. VH Group
  • 12.1.21. Virbac Group
  • 12.1.22. VIVAN Life Sciences Pvt. Limited
  • 12.1.23. Zoetis Inc.
• 12.2. Key Product Portfolio

13. Appendix

• 13.1. Discussion Guide
• 13.2. License & Pricing

LIST OF FIGURES

• FIGURE 1. ANTICOCCIDIAL DRUGS MARKET RESEARCH PROCESS
• FIGURE 2. ANTICOCCIDIAL DRUGS MARKET SIZE, 2023 VS 2030
• FIGURE 3. ANTICOCCIDIAL DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. ANTICOCCIDIAL DRUGS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
• FIGURE 5. ANTICOCCIDIAL DRUGS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. ANTICOCCIDIAL DRUGS MARKET DYNAMICS
• FIGURE 7. ANTICOCCIDIAL DRUGS MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
• FIGURE 8. ANTICOCCIDIAL DRUGS MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 9. ANTICOCCIDIAL DRUGS MARKET SIZE, BY ANIMAL TYPE, 2023 VS 2030 (%)
• FIGURE 10. ANTICOCCIDIAL DRUGS MARKET SIZE, BY ANIMAL TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 11. AMERICAS ANTICOCCIDIAL DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 12. AMERICAS ANTICOCCIDIAL DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 13. UNITED STATES ANTICOCCIDIAL DRUGS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 14. UNITED STATES ANTICOCCIDIAL DRUGS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 15. ASIA-PACIFIC ANTICOCCIDIAL DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 16. ASIA-PACIFIC ANTICOCCIDIAL DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 17. EUROPE, MIDDLE EAST & AFRICA ANTICOCCIDIAL DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 18. EUROPE, MIDDLE EAST & AFRICA ANTICOCCIDIAL DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 19. ANTICOCCIDIAL DRUGS MARKET, FPNV POSITIONING MATRIX, 2023
• FIGURE 20. ANTICOCCIDIAL DRUGS MARKET SHARE, BY KEY PLAYER, 2023

LIST OF TABLES

• TABLE 1. ANTICOCCIDIAL DRUGS MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. ANTICOCCIDIAL DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. ANTICOCCIDIAL DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 6. ANTICOCCIDIAL DRUGS MARKET SIZE, BY ANTIBIOTIC ANTICOCCIDIALS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 7. ANTICOCCIDIAL DRUGS MARKET SIZE, BY CHEMICAL DERIVATIVE ANTICOCCIDIALS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 8. ANTICOCCIDIAL DRUGS MARKET SIZE, BY IONOPHORE ANTICOCCIDIALS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. ANTICOCCIDIAL DRUGS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 10. ANTICOCCIDIAL DRUGS MARKET SIZE, BY AQUACULTURE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. ANTICOCCIDIAL DRUGS MARKET SIZE, BY LIVESTOCK, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. ANTICOCCIDIAL DRUGS MARKET SIZE, BY POULTRY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. AMERICAS ANTICOCCIDIAL DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 14. AMERICAS ANTICOCCIDIAL DRUGS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 15. AMERICAS ANTICOCCIDIAL DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 16. ARGENTINA ANTICOCCIDIAL DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 17. ARGENTINA ANTICOCCIDIAL DRUGS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 18. BRAZIL ANTICOCCIDIAL DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 19. BRAZIL ANTICOCCIDIAL DRUGS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 20. CANADA ANTICOCCIDIAL DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 21. CANADA ANTICOCCIDIAL DRUGS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 22. MEXICO ANTICOCCIDIAL DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 23. MEXICO ANTICOCCIDIAL DRUGS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 24. UNITED STATES ANTICOCCIDIAL DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 25. UNITED STATES ANTICOCCIDIAL DRUGS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 26. UNITED STATES ANTICOCCIDIAL DRUGS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 27. ASIA-PACIFIC ANTICOCCIDIAL DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 28. ASIA-PACIFIC ANTICOCCIDIAL DRUGS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 29. ASIA-PACIFIC ANTICOCCIDIAL DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 30. AUSTRALIA ANTICOCCIDIAL DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 31. AUSTRALIA ANTICOCCIDIAL DRUGS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 32. CHINA ANTICOCCIDIAL DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 33. CHINA ANTICOCCIDIAL DRUGS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 34. INDIA ANTICOCCIDIAL DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 35. INDIA ANTICOCCIDIAL DRUGS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 36. INDONESIA ANTICOCCIDIAL DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 37. INDONESIA ANTICOCCIDIAL DRUGS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 38. JAPAN ANTICOCCIDIAL DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 39. JAPAN ANTICOCCIDIAL DRUGS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 40. MALAYSIA ANTICOCCIDIAL DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 41. MALAYSIA ANTICOCCIDIAL DRUGS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 42. PHILIPPINES ANTICOCCIDIAL DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 43. PHILIPPINES ANTICOCCIDIAL DRUGS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 44. SINGAPORE ANTICOCCIDIAL DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 45. SINGAPORE ANTICOCCIDIAL DRUGS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 46. SOUTH KOREA ANTICOCCIDIAL DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 47. SOUTH KOREA ANTICOCCIDIAL DRUGS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 48. TAIWAN ANTICOCCIDIAL DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 49. TAIWAN ANTICOCCIDIAL DRUGS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 50. THAILAND ANTICOCCIDIAL DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 51. THAILAND ANTICOCCIDIAL DRUGS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 52. VIETNAM ANTICOCCIDIAL DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 53. VIETNAM ANTICOCCIDIAL DRUGS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 54. EUROPE, MIDDLE EAST & AFRICA ANTICOCCIDIAL DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 55. EUROPE, MIDDLE EAST & AFRICA ANTICOCCIDIAL DRUGS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 56. EUROPE, MIDDLE EAST & AFRICA ANTICOCCIDIAL DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 57. DENMARK ANTICOCCIDIAL DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 58. DENMARK ANTICOCCIDIAL DRUGS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 59. EGYPT ANTICOCCIDIAL DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 60. EGYPT ANTICOCCIDIAL DRUGS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 61. FINLAND ANTICOCCIDIAL DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 62. FINLAND ANTICOCCIDIAL DRUGS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 63. FRANCE ANTICOCCIDIAL DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 64. FRANCE ANTICOCCIDIAL DRUGS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 65. GERMANY ANTICOCCIDIAL DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 66. GERMANY ANTICOCCIDIAL DRUGS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 67. ISRAEL ANTICOCCIDIAL DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 68. ISRAEL ANTICOCCIDIAL DRUGS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 69. ITALY ANTICOCCIDIAL DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 70. ITALY ANTICOCCIDIAL DRUGS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 71. NETHERLANDS ANTICOCCIDIAL DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 72. NETHERLANDS ANTICOCCIDIAL DRUGS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 73. NIGERIA ANTICOCCIDIAL DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 74. NIGERIA ANTICOCCIDIAL DRUGS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 75. NORWAY ANTICOCCIDIAL DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 76. NORWAY ANTICOCCIDIAL DRUGS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 77. POLAND ANTICOCCIDIAL DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 78. POLAND ANTICOCCIDIAL DRUGS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 79. QATAR ANTICOCCIDIAL DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 80. QATAR ANTICOCCIDIAL DRUGS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 81. RUSSIA ANTICOCCIDIAL DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 82. RUSSIA ANTICOCCIDIAL DRUGS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 83. SAUDI ARABIA ANTICOCCIDIAL DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 84. SAUDI ARABIA ANTICOCCIDIAL DRUGS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 85. SOUTH AFRICA ANTICOCCIDIAL DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 86. SOUTH AFRICA ANTICOCCIDIAL DRUGS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 87. SPAIN ANTICOCCIDIAL DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 88. SPAIN ANTICOCCIDIAL DRUGS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 89. SWEDEN ANTICOCCIDIAL DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 90. SWEDEN ANTICOCCIDIAL DRUGS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 91. SWITZERLAND ANTICOCCIDIAL DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 92. SWITZERLAND ANTICOCCIDIAL DRUGS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 93. TURKEY ANTICOCCIDIAL DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 94. TURKEY ANTICOCCIDIAL DRUGS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 95. UNITED ARAB EMIRATES ANTICOCCIDIAL DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 96. UNITED ARAB EMIRATES ANTICOCCIDIAL DRUGS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 97. UNITED KINGDOM ANTICOCCIDIAL DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 98. UNITED KINGDOM ANTICOCCIDIAL DRUGS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 99. ANTICOCCIDIAL DRUGS MARKET, FPNV POSITIONING MATRIX, 2023
• TABLE 100. ANTICOCCIDIAL DRUGS MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 101. ANTICOCCIDIAL DRUGS MARKET LICENSE & PRICING